- Forums
- ASX - By Stock
- AVR
- HSV-2 Clinical Trial
HSV-2 Clinical Trial, page-10
-
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.79 |
Change
-0.120(0.67%) |
Mkt cap ! $347.9M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.79 | $30.83K | 1.717K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7 | $17.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.97 | 46 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 125 | 17.800 |
1 | 10 | 17.790 |
1 | 26 | 17.760 |
1 | 93 | 17.710 |
1 | 443 | 17.700 |
Price($) | Vol. | No. |
---|---|---|
18.000 | 286 | 3 |
18.020 | 36 | 2 |
18.030 | 64 | 1 |
18.140 | 45 | 1 |
18.240 | 500 | 1 |
Last trade - 11.15am 16/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online